Investigation of the pharmacological treatment patterns of Chinese patients with major depressive disorder under real-world settings using multi-channel sequence analysis

Investigation of the pharmacological treatment patterns of Chinese patients with major depressive disorder under real-world settings using multi-channel sequence analysis

BackgroundDespite many treatment guidelines available now, the treatment patterns of major depressive disorder (MDD) in China haven't been well-understood due to complexity and diversity.AimTo describe pharmacological treatment patterns of MDD patients in real-world settings using electronic he...

Full description

Bibliographic Details
Main Authors:	Tao Wu, Sijia Dong, Lu Yang, Hong Qiu, David Mellor, Jun Chen, Yifeng Xu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Psychiatry
Subjects:	major depressive disorder antidepressants multi-channel sequence analysis treatment patterns electronic health records
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1089504/full

Similar Items

Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?
by: Yuncheng Zhu, et al.
Published: (2023-11-01)

The pharmacological management of depression – Update 2017
by: Elzbieta Osuch, et al.
Published: (2017-03-01)

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment
by: Lin Yao, et al.
Published: (2020-12-01)

The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis
by: Claudia Savia Guerrera, et al.
Published: (2023-11-01)

Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments
by: Elisabetta Maffioletti, et al.
Published: (2020-09-01)

Less basal thyrotropin levels predict antidepressant response in patients with major depression
by: R. Navinés, et al.
Published: (2022-06-01)

MRI predictors of pharmacotherapy response in major depressive disorder
by: Andrew R. Gerlach, et al.
Published: (2022-01-01)

Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China
by: Zhu Y, et al.
Published: (2023-04-01)

Antidepressant Treatment-Induced State-Dependent Reconfiguration of Emotion Regulation Networks in Major Depressive Disorder
by: Lei Zhao, et al.
Published: (2022-01-01)

Pharmacological Treatments for Patients with Treatment-Resistant Depression
by: Valerie L. Ruberto, et al.
Published: (2020-06-01)

Heart Rate Variability for the Prediction of Treatment Response in Major Depressive Disorder
by: Kwan Woo Choi, et al.
Published: (2020-06-01)

The effects of physiotherapy methods combined with respiratory and relaxation exercises on patients with major depression
by: Elisa Calisgan, et al.
Published: (2020-12-01)

Exploring the Role and Potential of Probiotics in the Field of Mental Health: Major Depressive Disorder
by: Dinyadarshini Johnson, et al.
Published: (2021-05-01)

Psychotherapy employed additionally to Psychopharmacotherapy is not related to Better Treatment Outcome in Major Depressive Disorder
by: L. Bartova, et al.
Published: (2022-06-01)

Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands
by: Cornelis F. Vos, et al.
Published: (2021-10-01)

Functional connectivity analysis on electroencephalography signals reveals potential biomarkers for treatment response in major depression
by: Shiau-Shian Huang, et al.
Published: (2023-08-01)

A study to identify unrecognized bipolar disorder in patients of major depressive disorder taking antidepressants
by: Kinjal Bhupendrasinh Chauhan, et al.
Published: (2022-12-01)

Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
by: Caroline Kamp Jørgensen, et al.
Published: (2021-08-01)

Taking the perspective that a depressive state reflects inflammation: implications for the use of antidepressants
by: Jill Leslie Littrell
Published: (2012-08-01)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
by: Bing Cao, et al.
Published: (2019-01-01)

Clinical perspectives on the influence of drug formulation on patient tolerability and use of commonly prescribed antidepressants in major depressive disorder
by: Matthew A Fuller, et al.
Published: (2013-01-01)

Clinical Phenotypes Characterization in Pharmacogenetics Testing Trials for Major Depressive Disorder Treatment
by: A. Minelli
Published: (2022-06-01)

Addition of aerobic exercise to antidepressant drug monotherapy for major depressive disorder in adults
by: Camila Sanhueza Pastén, et al.
Published: (2022-01-01)

Assessment of pharmacological strategies for management of major depressive disorder and their costs after an inadequate response to first-line antidepressant treatment in primary care
by: Sicras-Mainar Antoni, et al.
Published: (2012-08-01)

Novel Pharmacological Approaches to the Treatment of Depression
by: Elias Elias, et al.
Published: (2022-01-01)

Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder
by: Yaping Wang, et al.
Published: (2023-08-01)

Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
by: Haiyan Liu, et al.
Published: (2023-02-01)

The role of pharmacogenetics in the treatment of major depressive disorder: a critical review
by: Stefano Barlati, et al.
Published: (2023-11-01)

The Impact of Residual Symptoms in Major Depression
by: Joshua A. Israel
Published: (2010-08-01)

Exploring the Role of Gut Microbiota in Major Depressive Disorder and in Treatment Resistance to Antidepressants
by: Andrea Fontana, et al.
Published: (2020-08-01)

Blue again: Perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression
by: Paul eAndrews, et al.
Published: (2011-07-01)

Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder
by: Nadine Dreimüller, et al.
Published: (2019-01-01)

Uncovering the Roles of MicroRNAs in Major Depressive Disorder: From Candidate Diagnostic Biomarkers to Treatment Response Indicators
by: Claudia Homorogan, et al.
Published: (2021-10-01)

When to hold and when to fold: Early prediction of nonresponse to transcranial magnetic stimulation in major depressive disorder
by: Harold A. Sackeim, et al.
Published: (2024-03-01)

The influence of general practitioner and patient sex on the treatment of major depression
by: Elisabeth Jufresa-Blanch, et al.
Published: (2023-11-01)

From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder
by: Bangshan Liu, et al.
Published: (2017-09-01)

Cortisol and Major Depressive Disorder—Translating Findings From Humans to Animal Models and Back
by: L. Sanjay Nandam, et al.
Published: (2020-01-01)

The Role of Beta-Adrenergic Receptors in Depression and Resilience
by: Hongxing Zhang, et al.
Published: (2022-09-01)

Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis
by: Geneviève Gauthier, et al.
Published: (2017-06-01)

Predicting the Treatment Outcomes of Antidepressants Using a Deep Neural Network of Deep Learning in Drug-Naïve Major Depressive Patients
by: Ping-Lin Tsai, et al.
Published: (2022-04-01)